Of note, the survival effect of MAP4K1 expression in relation to TGF‐β signaling became more significant in metastatic cutaneous melanoma compared to primary cutaneous melanoma (Figure S19b, Supporting Information). Here, MAP4K1 is linked to cutaneous melanoma.